TY - JOUR T1 - LAMOTRIGINE AS ADD-ON THERAPY IN CHILDREN WITH DRUG-RESISTANT EPILEPSY (IRANIAN EXPERIENCE) TT - JF - MJIRI JO - MJIRI VL - 17 IS - 1 UR - http://mjiri.iums.ac.ir/article-1-714-en.html Y1 - 2003 SP - 15 EP - 18 KW - Lamotrigine KW - refractory epilepsy KW - add-on therapy. N2 - Lamotrigine (LTG), a newly developed antiepileptic drug (AED), is efficacious in treating refractory epilepsy. This study was designed to evaluate the efficacy and safety of LTG as add-on therapy in 40 children with refractory epilepsy. The trial was an open-labeled prospective study in children with drug-resistant epilepsy aged M3 ER -